Jodinat

Potassium Iodide, the active ingredient in Jodinat, is an iodine supplement presented as an unknown/unknown for oral use. It is used to protect the thyroid gland from radioactive iodine exposure and to provide iodine supplementation for thyroid protection in at‑risk populations.

GNH USA supplies Jodinat as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Jodinat is an iodine supplement that acts on the thyroid gland to block uptake of harmful iodine species. - Radiation emergency prophylaxis: reduces thyroid uptake of radioactive iodine, lowering the risk of radiation‑induced thyroid damage. - Iodine deficiency supplementation: provides stable iodine to support normal thyroid function in populations with insufficient dietary iodine. - Pre‑radioiodine therapy preparation: blocks thyroid uptake of administered radioactive iodine to protect normal thyroid tissue during therapeutic procedures.

Adverse reactions may occur with oral potassium iodide administration.

Common Side Effects: - Metallic taste in the mouth. - Nausea or mild vomiting. - Stomach discomfort or abdominal cramps. - Headache. - Mild skin rash or itching. - Increased salivation.

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction. - Acute thyroid dysfunction (hypothyroidism or hyperthyroidism). - Angioedema involving face, lips, or throat. - Severe skin eruption such as Stevens‑Johnson syndrome. - Persistent high serum potassium levels. - Pulmonary edema in susceptible individuals.

Before using Jodinat, consider the following safety measures. - Assess iodine status: verify that supplementation is medically indicated. - Allergy screening: avoid use in individuals with known potassium iodide or iodine allergy. - Thyroid disorders: use cautiously in patients with existing hyper‑ or hypothyroidism. - Pregnancy and lactation: evaluate risk‑benefit ratio before prescribing. - Renal impairment: monitor potassium levels in patients with reduced kidney function. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Potassium iodide may interact with several medications.

Major Interactions (Avoid): - Levothyroxine: iodine supplementation can diminish the effectiveness of levothyroxine therapy. - Antithyroid drugs (e.g., methimazole, propylthiouracil): may counteract the intended thyroid‑blocking effect. - Radioactive iodine therapy: concurrent use reduces therapeutic uptake of the radioactive isotope.

Moderate Interactions (Monitor Closely): - Diuretics (especially potassium‑sparing): may increase serum potassium levels. - ACE inhibitors or ARBs: monitor for hyperkalaemia. - NSAIDs: may exacerbate gastrointestinal irritation. - Corticosteroids: can alter iodine metabolism. - Oral contraceptives: may affect iodine balance.